Stockreport

Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks [Yahoo! Finance]

Radiopharm Theranostics Limited - American Depositary Shares  (RADX) 
PDF is 27/30 with a full readout expected in May–June and an FDA meeting planned around June to discuss a Phase III registrational design. All four therapeutic programs (R [Read more]